Skip to main content
      RT @DrGomezPuerta: More data from @rheum_covid presented by @mugartegil showing prognostic factors in patients with SLE

      José A. Gómez Puerta DrGomezPuerta

      3 years 6 months ago
      More data from @rheum_covid presented by @mugartegil showing prognostic factors in patients with SLE & COVID-19 Factors related with poor prognosis: -Male, Age, Comorbidities -Time period (1st wave) -GC doses -Disease activity - No enough data for RTX or Beli #EULAR2021 #LUPUS https://t.co/ts8QsyR5KA
      RT @RichardPAConway: What is the highest level reaction you have seen to COVID vaccine? @RheumNow #EULAR2021

      Richard Conway RichardPAConway

      3 years 6 months ago
      What is the highest level reaction you have seen to COVID vaccine? @RheumNow #EULAR2021
      RT @RichardPAConway: Dr Pupim presents data on GM-CSF inhibitor mavrilimumab to treat non-ventilated COVID-19 with syste

      Richard Conway RichardPAConway

      3 years 6 months ago
      Dr Pupim presents data on GM-CSF inhibitor mavrilimumab to treat non-ventilated COVID-19 with systemic hyperinflammation 65% ⬇️ ventilation/death day 29 (p=0.02) 61% ⬇️ death day 29 (p=0.07) @RheumNow #EULAR2021 Abstr#LB0001 https://t.co/VBPyv4Kbv7
      RT @RichardPAConway: Dr Ruperto on secukinumab in ERA and JPsA subtypes of JIA. HR 0.28; 95%CI 0.13–0.63 p<0.001 fo

      Richard Conway RichardPAConway

      3 years 6 months ago
      Dr Ruperto on secukinumab in ERA and JPsA subtypes of JIA. HR 0.28; 95%CI 0.13–0.63 p<0.001 for flare to week 100. 87.2%, 83.7%, 67.4%, 38.4% and 24.4% of pts achieved JIA ACR 30/50/70/90/100 @RheumNow #EULAR2021 Abstr#LB0004 https://t.co/envFupqqV2
      RT @RichardPAConway: Dr Diekmann presents on rheumatic irAEs in different cancers. More common melanoma than NSCLC. SpA

      Richard Conway RichardPAConway

      3 years 6 months ago
      Dr Diekmann presents on rheumatic irAEs in different cancers. More common melanoma than NSCLC. SpA most common. Occurrence associated better tumour response. Good response to immunosuppression @RheumNow #EULAR2021 Abstr#POS0293 https://t.co/0tSHSbRq40
      RT @RichardPAConway: Dr Chatzis presents risk prediction model for MALT lymphoma in Sjogrens. Cryoglobulinaemia and ESSD

      Richard Conway RichardPAConway

      3 years 6 months ago
      Dr Chatzis presents risk prediction model for MALT lymphoma in Sjogrens. Cryoglobulinaemia and ESSDAI at diagnosis only predictors. AUROC 0.78 for model @RheumNow #EULAR2021 Abstr#POS0290 https://t.co/cLmiMgnpwF
      RT @KDAO2011: Quiz yourself.
      Which of the following is NOT a risk factor for HCQ associated conduction abnormalities? #

      k dao KDAO2011

      3 years 6 months ago
      Quiz yourself. Which of the following is NOT a risk factor for HCQ associated conduction abnormalities? #EULAR2021 @RheumNow
      RT @KDAO2011: Deep learning for SLE #POS0351
      👉use of AI to ID potential targets/dz pathways
      👉gene ranked using met

      k dao KDAO2011

      3 years 6 months ago
      Deep learning for SLE #POS0351 👉use of AI to ID potential targets/dz pathways 👉gene ranked using metric expression & interactivity 👉many IFN and JAK/STAT genes ranked high 👉strong assc w/new pathways related to CD4+Tcell different'n, macs, denditric cells #EULAR2021 @rheumnow https://t.co/JF7NFeX4E7
      RT @AurelieRheumo: Not an expert in capillaroscopy? Not an issue! https://t.co/jHNKDtafQC: an automatic image reading sy

      Aurelie Najm AurelieRheumo

      3 years 6 months ago
      Not an expert in capillaroscopy? Not an issue! https://t.co/jHNKDtafQC: an automatic image reading system able to detect: -Normal capillaries Se 79.8% Spe 82% -Megacapillaries Se 89.4% Spe 78.8% -Hemorrhages (Se 71% She 73.9%) compared to expert #POS0256 #EULAR2021 @Rheumnow https://t.co/MR8enBO0de
      RT @AurelieRheumo: Wait, let me scan your joints first! Early arthritis clinics: US examination prior first clinical rev

      Aurelie Najm AurelieRheumo

      3 years 6 months ago
      Wait, let me scan your joints first! Early arthritis clinics: US examination prior first clinical review in cohort of 163: ⬇️ ⭐️time to diag from mean 31 days to 12 ⭐️n° of clinical visits - 114 visits over a year ⭐️n° of revised diag at 1yr 5 vs 16% #POS0260 #EULAR2021 @Rheumnow https://t.co/CLkNqZUJVQ
      RT @AurelieRheumo: Subclinical US enthesitis in 174 IBD patients w/ or w/out PSO:
      -High prevalence of structural damage

      Aurelie Najm AurelieRheumo

      3 years 6 months ago
      Subclinical US enthesitis in 174 IBD patients w/ or w/out PSO: -High prevalence of structural damage ≥1 enthesis 83.4% -≥1 active enthesitis 25% in IBD + PSO: -⬆️ ≥ 1 thickened enthesis 86% vs 64% p=0.009) -⬆️of PD signal at knee examination. #POS0265 @RheumNow #EULAR2021 https://t.co/8f7G5ku1kc
      RT @AurelieRheumo: Adelphi RA Disease Specific Program: Physician survey on T2T strategy implementation in RA. #POS0305

      Aurelie Najm AurelieRheumo

      3 years 6 months ago
      Adelphi RA Disease Specific Program: Physician survey on T2T strategy implementation in RA. #POS0305 What is main objective in RA T2T? @Rheumnow #EULAR2021
      RT @AurelieRheumo: ESPOIR cohort 598 patients w/ EVA fatigue for 10yrs: 3 fatigue trajectories high, moderate and low,

      Aurelie Najm AurelieRheumo

      3 years 6 months ago
      ESPOIR cohort 598 patients w/ EVA fatigue for 10yrs: 3 fatigue trajectories high, moderate and low, consistent over time. Predictors of high fatigue trajectory: female gender, pain, psychological distress, presence of sicca symptoms. Effect of tmts? @Rheumnow #EULAR2021 #POS0308 https://t.co/iMLKFPikaR
      RT @AurelieRheumo: Depression is not only associated with high PGA but also with inflammatory markers in RA! Cross-secti

      Aurelie Najm AurelieRheumo

      3 years 6 months ago
      Depression is not only associated with high PGA but also with inflammatory markers in RA! Cross-sectional study of 258 patients: Depression (PHQ-9>10) associated with DAS28-ESR OR 1.1, DAS28 CRP OR 1.1, PGA AND CRP OR1.3 in multivariate analysis. @Rheumnow #POS0312 #EULAR2021 https://t.co/66CaqLp61r
      RT @AurelieRheumo: Is genetic of RA remission different? Neither genetic risk score comprising RA susceptibility variant

      Aurelie Najm AurelieRheumo

      3 years 6 months ago
      Is genetic of RA remission different? Neither genetic risk score comprising RA susceptibility variants (OR 0.99 0.94-1.03) nor HLA-SE (OR 0.8 0.75-1.01) are associated with DAS28CRP<2.6 at 6 month in this MA of 8 inception cohorts (4425 patients) @RheumNow #EULAR21 POS0348 https://t.co/rvGovxTlRo
      ×